• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC From B-Lymphocyte(Facioscapulohumeral Muscular Dystrophy 1)

  • For research use only

Cat No.

ABC-SC2036

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

B-Lymphocyte

Disease

Facioscapulohumeral Muscular Dystrophy 1

Storage

Liquid Nitrogen

Cell Type: iPSC; Disease: Facioscapulohumeral Muscular Dystrophy 1; FSHD1.

Product Image

Description

HighQC™ Human Induced Pluripotent Stem Cells (iPSCs) From B Lymphocytes – Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) are generated from human peripheral blood–derived B lymphocytes obtained from an affected individual. Facioscapulohumeral Muscular Dystrophy Type 1 is a heritable neuromuscular disorder. These cells display tight colony boundaries, high nuclear-to-cytoplasmic ratios, and clonal growth patterns. Reprogramming was performed using a non-integrating approach, which transiently expresses key human transcription factors to initiate the reprogramming process. These iPSCs exhibit pluripotency, with the ability to differentiate into types of all three germ layers under defined conditions, and express the pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC From B-Lymphocyte (Facioscapulohumeral Muscular Dystrophy 1), HighQC™ hiPSC FSHD1, hiPSC-FSHD1, HighQC™ Human Induced Pluripotent Stem Cells From B-Lymphocyte-Facioscapulohumeral Muscular Dystrophy Type 1

Species

Human

Cat.No

ABC-SC2036

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

B-Lymphocyte

Disease

Facioscapulohumeral Muscular Dystrophy 1

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSCs derived from B lymphocytes of individuals with Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1), also known as FSHD1 iPSCs, can be directed to differentiate into skeletal muscle lineage cells, including myogenic progenitors and mature myotubes, enabling investigation of muscle development, degeneration, and regeneration associated with FSHD1. These cells are also valuable for in vitro disease modeling, as they retain patient-specific genetic and epigenetic features, supporting studies of pathogenic mechanisms, gene function, and dysregulated signaling pathways underlying FSHD1.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From B-Lymphocyte(Facioscapulohumeral Muscular Dystrophy 1)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button